Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 01-2000 | 12-1999 | 11-1999 | 10-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,555 | -2,760 | N/A | N/A | -210 |
| Depreciation Amortization | 1,193 | 2,210 | N/A | N/A | 1,640 |
| Accounts receivable | 1,048 | N/A | N/A | -97 | N/A |
| Accounts payable and accrued liabilities | 2,596 | N/A | N/A | -73 | N/A |
| Other Working Capital | 2,847 | -3,030 | N/A | N/A | -5,160 |
| Other Operating Activity | -1,730 | 0 | 0 | 170 | 60 |
| Operating Cash Flow | $1,399 | $-3,580 | $N/A | $N/A | $-3,670 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,173 | -3,700 | N/A | N/A | -2,440 |
| Net Acquisitions | -5,813 | -390 | N/A | N/A | 0 |
| Sale Of Investment | N/A | N/A | N/A | 989 | N/A |
| Other Investing Activity | -2,481 | 990 | 0 | -989 | 600 |
| Investing Cash Flow | $-9,467 | $-3,100 | $N/A | $N/A | $-1,840 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,000 | N/A | N/A | N/A | N/A |
| Debt Issued | 0 | N/A | N/A | 41 | N/A |
| Debt Repayment | -851 | N/A | N/A | -42 | N/A |
| Common Stock Issued | 211 | N/A | N/A | 468 | N/A |
| Other Financing Activity | 8,881 | 710 | 0 | -467 | 590 |
| Financing Cash Flow | $13,241 | $710 | $N/A | $N/A | $590 |
| Beginning Cash Position | 3,203 | 9,180 | N/A | N/A | 9,180 |
| End Cash Position | 8,376 | 3,200 | N/A | N/A | 4,250 |
| Net Cash Flow | $5,173 | $-5,980 | $N/A | $N/A | $-4,920 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,399 | -3,580 | N/A | N/A | -3,670 |
| Capital Expenditure | -1,173 | N/A | N/A | -990 | N/A |
| Free Cash Flow | 226 | -3,580 | 0 | -990 | -3,670 |